Pharmaceutical composition for treating diabetic encephalopathy

A technology for diabetic encephalopathy and a composition is applied in the field of pharmaceutical compositions for the treatment of diabetic encephalopathy and their preparation, and can solve problems such as inability to fundamentally solve problems, side effects, treatment failure and the like

Inactive Publication Date: 2015-12-09
JINAN XINGYI MEDICAL TECH
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although western medicine emerges in an endless stream, it cannot fundamentally solve the problem, and western medicine treatment has certain side effects and "treatment failure"

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating diabetic encephalopathy
  • Pharmaceutical composition for treating diabetic encephalopathy
  • Pharmaceutical composition for treating diabetic encephalopathy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Embodiment 1: The pharmaceutical composition and preparation method thereof for the treatment of diabetic encephalopathy

[0041] The composition and parts by weight of the bulk drug of the pharmaceutical composition for the treatment of diabetic encephalopathy are:

[0042]5 parts by weight of Imperatae, 160 parts by weight of Imperata chinensis 160 parts by weight, 150 parts by weight, 150 parts by weight, 2 parts by weight, 0.6 parts by weight, 0.6 parts by weight, 0.15 parts by weight, of oreoside A;

[0043] Preparation:

[0044] (1) According to the ratio of raw materials, take Ligularia fruticosa and Imperata chinensis, mix well, ultrafinely pulverize to 90 microns, use ethanol with a concentration of 65% by weight as a solvent, and heat and reflux for extraction. The number of extractions is 3 times, and the extraction time for each For 2 hours, the amount of solvent used each time is 15 times of the total weight of Ligularia fruticosa and Imperata chinensis, a...

Embodiment 2

[0047] Embodiment 2: the pharmaceutical composition for the treatment of diabetic encephalopathy and its preparation method

[0048] The composition and parts by weight of the bulk drug of the pharmaceutical composition for the treatment of diabetic encephalopathy are:

[0049] 3 parts by weight of Imperatae, 170 parts by weight of Ligularia chinensis 140 parts by weight, 140 parts by weight, 3 parts by weight, 0.4 parts by weight, 0.4 parts by weight, oreoside A;

[0050] Preparation:

[0051] (1) According to the ratio of raw materials, take Ligularia fruticosa and Imperata chinensis, mix well, ultrafinely pulverize to 90 microns, use ethanol with a concentration of 65% by weight as a solvent, and heat and reflux for extraction. The number of extractions is 3 times, and the extraction time for each For 2 hours, the amount of solvent used each time is 15 times of the total weight of Ligularia fruticosa and Imperata chinensis, and filtered to obtain medicinal residue A and an...

Embodiment 3

[0054] Embodiment 3: the pharmaceutical composition for the treatment of diabetic encephalopathy and its preparation method

[0055] The composition and parts by weight of the bulk drug of the pharmaceutical composition for the treatment of diabetic encephalopathy are:

[0056] 7 parts by weight of Imperatae, 150 parts by weight of Ligularia fruticosa 160 parts by weight, 1 part by weight, 1 part by weight, 0.8 part by weight, 0.1 part by weight, of oreoside A;

[0057] Preparation:

[0058] (1) According to the ratio of raw materials, take Ligularia fruticosa and Imperata chinensis, mix well, ultrafinely pulverize to 90 microns, use ethanol with a concentration of 65% by weight as a solvent, and heat and reflux for extraction. The number of extractions is 3 times, and the extraction time for each For 2 hours, the amount of solvent used each time is 15 times of the total weight of Ligularia fruticosa and Imperata chinensis, and filtered to obtain medicinal residue A and an ex...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a pharmaceutical composition for treating diabetic encephalopathy and a preparation method thereof. The pharmaceutical composition is prepared by cylindrin, ligularia achyrotricha, lancea tibetica, Curcurbitacin IIa, bamboo reed terpene and oroxylum indicum glycoside A according to proportion. The pharmaceutical composition can be prepared into various forms according to a conventional preparation process and is evident in curative effect on the diabetic encephalopathy.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, in particular to a pharmaceutical composition for treating diabetic encephalopathy and a preparation method thereof. Background technique [0002] Diabetes mellitus is a metabolic disease characterized by hyperglycemia and associated with various complications caused by relative or absolute insufficiency of insulin secretion. It is a common disease in the department of endocrinology. Diabetes is divided into type 1 diabetes, type 2 diabetes and gestational diabetes. Among them, type 2 diabetes accounts for more than 95% of the total number of diabetes, and its degree of harm is also the greatest. It can cause diseases including nervous system disease, circulatory system disease, kidney disease, eye disease and Multiple acute and chronic complications of podiatry. Diabetes itself and its complications seriously endanger human health, and the treatment of diabetes has become ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/80A61P3/10A61P25/00A61K31/575A61K31/56A61K31/7048
Inventor 张秀华
Owner JINAN XINGYI MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap